Disease | influenza |
Phenotype | C0021390|inflammatory bowel disease |
Sentences | 5 |
PubMedID- 26351392 | Background and aims: data on the efficacy and safety of seasonal influenza vaccines in patients with inflammatory bowel disease (ibd) remain scarce. |
PubMedID- 21757451 | Serological response to the 2009 h1n1 influenza vaccination in patients with inflammatory bowel disease. |
PubMedID- 23160078 | [the efficiency of influenza vaccines in patients with inflammatory bowel disease on immunosuppressive therapy]. |
PubMedID- 24690681 | In the context of the clinical trial micivax, designed to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (ibd) receiving immunosuppressive therapy with patients not receiving immunosuppressants, we monitored the ex-vivo t cell response directed against the multidose non-adjuvanted pandemic 2009 h1n1 vaccine panenza. |
PubMedID- 25384624 | Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy. |
Page: 1